Significant Association of MMP2 Promoter Genotypes to Asthma Susceptibility in Taiwan

Matrix metalloproteinase 2 (MMP2) is reported to be overexpressed in asthma; however, its genotypic contribution to asthma is not well studied. Therefore, we examined the association of MMP2 genotypes with asthma risk among Taiwanese. One hundred and ninety-eight asthma patients and 453 non-asthmati...

Full description

Saved in:
Bibliographic Details
Published in:In vivo (Athens) 2020-11, Vol.34 (6), p.3181-3186
Main Authors: Chen, Li-Hsiou, Chiu, Kuo-Liang, Hsia, Te-Chun, Lee, Yen-Hsien, Shen, Te-Chun, Li, Chia-Hsiang, Shen, Yi-Cheng, Chang, Wen-Shin, Tsai, Chia-Wen, Bau, DA-Tian
Format: Article
Language:English
Subjects:
Asthma - epidemiology
Asthma - genetics
Case-Control Studies
Gene Frequency
Genetic Predisposition to Disease
Genotype
Humans
Matrix Metalloproteinase 2 - genetics
Polymorphism, Single Nucleotide
Promoter Regions, Genetic
Taiwan - epidemiology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c387t-f0257360c23d5a1d2818805edaeee859edb44e58cb01132a470223bcfc3057193
cites
container_end_page 3186
container_issue 6
container_start_page 3181
container_title In vivo (Athens)
container_volume 34
creator Chen, Li-Hsiou
Chiu, Kuo-Liang
Hsia, Te-Chun
Lee, Yen-Hsien
Shen, Te-Chun
Li, Chia-Hsiang
Shen, Yi-Cheng
Chang, Wen-Shin
Tsai, Chia-Wen
Bau, DA-Tian
description Matrix metalloproteinase 2 (MMP2) is reported to be overexpressed in asthma; however, its genotypic contribution to asthma is not well studied. Therefore, we examined the association of MMP2 genotypes with asthma risk among Taiwanese. One hundred and ninety-eight asthma patients and 453 non-asthmatic subjects were determined with respect to their MMP2 -1306 (rs243845) and -735 (rs2285053) genotypes. CT and TT at MMP2 rs243845 are 17.7% and 1.5% among asthma cases, whereas their presence in healthy subjects is at 28.1% and 2.4%, respectively (p for trend=0.0118). In detail, the CT genotype in MMP2 rs243845 was associated with a decreased asthma risk [adjusted odds ratio (OR)=0.57, 95% confidence interval (CI)=0.37-0.78, p=0.0040], and the T allele conferred a significantly lower asthma risk compared to the wild-type C allele (adjusted OR=0.55, 95%CI=0.43-0.77, p=0.0042). No significance was found for MMP2 rs2285053. The genotype of CT in MMP2 rs243845 may serve as a novel biomarker in determining susceptibility to asthma in Taiwan.
doi_str_mv 10.21873/invivo.12153
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7811679</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2457691674</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-f0257360c23d5a1d2818805edaeee859edb44e58cb01132a470223bcfc3057193</originalsourceid><addsrcrecordid>eNpVkc1LAzEQxYMotlaPXiVHL6v5bLIXQUSrULHQFryFbDbbRnaTukkr_e9dbRU9zWF-vHnzHgDnGF0RLAW9dn7jNuEKE8zpAehjkeNMcJYfgj4iXGaS49ceOInxDaGhQIgcgx6lmDFGSB_Mp27hXeWM9gnexhiM08kFD0MFn58nBE7a0IRkWziyPqTtykaYQkemZaPhdB2NXSVXuNqlLXQezrT70P4UHFW6jvZsPwdg_nA_u3vMxi-jp7vbcWaoFCmrOoOCDpEhtOQal0RiKRG3pbbWSp7bsmDMcmkKhDElmglECC1MZSjiAud0AG52uqt10djSWJ9aXatV6xrdblXQTv3feLdUi7BRQmI8FF8Cl3uBNryvbUyqcd1Lda29DeuoCONimHco69Bsh5o2xNja6vcMRuq7CrWrQn1X0fEXf7390j_Z0088TYc7</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2457691674</pqid></control><display><type>article</type><title>Significant Association of MMP2 Promoter Genotypes to Asthma Susceptibility in Taiwan</title><source>PubMed Central</source><creator>Chen, Li-Hsiou ; Chiu, Kuo-Liang ; Hsia, Te-Chun ; Lee, Yen-Hsien ; Shen, Te-Chun ; Li, Chia-Hsiang ; Shen, Yi-Cheng ; Chang, Wen-Shin ; Tsai, Chia-Wen ; Bau, DA-Tian</creator><creatorcontrib>Chen, Li-Hsiou ; Chiu, Kuo-Liang ; Hsia, Te-Chun ; Lee, Yen-Hsien ; Shen, Te-Chun ; Li, Chia-Hsiang ; Shen, Yi-Cheng ; Chang, Wen-Shin ; Tsai, Chia-Wen ; Bau, DA-Tian</creatorcontrib><description>Matrix metalloproteinase 2 (MMP2) is reported to be overexpressed in asthma; however, its genotypic contribution to asthma is not well studied. Therefore, we examined the association of MMP2 genotypes with asthma risk among Taiwanese. One hundred and ninety-eight asthma patients and 453 non-asthmatic subjects were determined with respect to their MMP2 -1306 (rs243845) and -735 (rs2285053) genotypes. CT and TT at MMP2 rs243845 are 17.7% and 1.5% among asthma cases, whereas their presence in healthy subjects is at 28.1% and 2.4%, respectively (p for trend=0.0118). In detail, the CT genotype in MMP2 rs243845 was associated with a decreased asthma risk [adjusted odds ratio (OR)=0.57, 95% confidence interval (CI)=0.37-0.78, p=0.0040], and the T allele conferred a significantly lower asthma risk compared to the wild-type C allele (adjusted OR=0.55, 95%CI=0.43-0.77, p=0.0042). No significance was found for MMP2 rs2285053. The genotype of CT in MMP2 rs243845 may serve as a novel biomarker in determining susceptibility to asthma in Taiwan.</description><identifier>ISSN: 0258-851X</identifier><identifier>EISSN: 1791-7549</identifier><identifier>DOI: 10.21873/invivo.12153</identifier><identifier>PMID: 33144422</identifier><language>eng</language><publisher>Greece: International Institute of Anticancer Research</publisher><subject>Asthma - epidemiology ; Asthma - genetics ; Case-Control Studies ; Gene Frequency ; Genetic Predisposition to Disease ; Genotype ; Humans ; Matrix Metalloproteinase 2 - genetics ; Polymorphism, Single Nucleotide ; Promoter Regions, Genetic ; Taiwan - epidemiology</subject><ispartof>In vivo (Athens), 2020-11, Vol.34 (6), p.3181-3186</ispartof><rights>Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.</rights><rights>Copyright 2020, International Institute of Anticancer Research 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-f0257360c23d5a1d2818805edaeee859edb44e58cb01132a470223bcfc3057193</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811679/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811679/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,733,786,790,891,27957,27958,53827,53829</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33144422$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Li-Hsiou</creatorcontrib><creatorcontrib>Chiu, Kuo-Liang</creatorcontrib><creatorcontrib>Hsia, Te-Chun</creatorcontrib><creatorcontrib>Lee, Yen-Hsien</creatorcontrib><creatorcontrib>Shen, Te-Chun</creatorcontrib><creatorcontrib>Li, Chia-Hsiang</creatorcontrib><creatorcontrib>Shen, Yi-Cheng</creatorcontrib><creatorcontrib>Chang, Wen-Shin</creatorcontrib><creatorcontrib>Tsai, Chia-Wen</creatorcontrib><creatorcontrib>Bau, DA-Tian</creatorcontrib><title>Significant Association of MMP2 Promoter Genotypes to Asthma Susceptibility in Taiwan</title><title>In vivo (Athens)</title><addtitle>In Vivo</addtitle><description>Matrix metalloproteinase 2 (MMP2) is reported to be overexpressed in asthma; however, its genotypic contribution to asthma is not well studied. Therefore, we examined the association of MMP2 genotypes with asthma risk among Taiwanese. One hundred and ninety-eight asthma patients and 453 non-asthmatic subjects were determined with respect to their MMP2 -1306 (rs243845) and -735 (rs2285053) genotypes. CT and TT at MMP2 rs243845 are 17.7% and 1.5% among asthma cases, whereas their presence in healthy subjects is at 28.1% and 2.4%, respectively (p for trend=0.0118). In detail, the CT genotype in MMP2 rs243845 was associated with a decreased asthma risk [adjusted odds ratio (OR)=0.57, 95% confidence interval (CI)=0.37-0.78, p=0.0040], and the T allele conferred a significantly lower asthma risk compared to the wild-type C allele (adjusted OR=0.55, 95%CI=0.43-0.77, p=0.0042). No significance was found for MMP2 rs2285053. The genotype of CT in MMP2 rs243845 may serve as a novel biomarker in determining susceptibility to asthma in Taiwan.</description><subject>Asthma - epidemiology</subject><subject>Asthma - genetics</subject><subject>Case-Control Studies</subject><subject>Gene Frequency</subject><subject>Genetic Predisposition to Disease</subject><subject>Genotype</subject><subject>Humans</subject><subject>Matrix Metalloproteinase 2 - genetics</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Promoter Regions, Genetic</subject><subject>Taiwan - epidemiology</subject><issn>0258-851X</issn><issn>1791-7549</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpVkc1LAzEQxYMotlaPXiVHL6v5bLIXQUSrULHQFryFbDbbRnaTukkr_e9dbRU9zWF-vHnzHgDnGF0RLAW9dn7jNuEKE8zpAehjkeNMcJYfgj4iXGaS49ceOInxDaGhQIgcgx6lmDFGSB_Mp27hXeWM9gnexhiM08kFD0MFn58nBE7a0IRkWziyPqTtykaYQkemZaPhdB2NXSVXuNqlLXQezrT70P4UHFW6jvZsPwdg_nA_u3vMxi-jp7vbcWaoFCmrOoOCDpEhtOQal0RiKRG3pbbWSp7bsmDMcmkKhDElmglECC1MZSjiAud0AG52uqt10djSWJ9aXatV6xrdblXQTv3feLdUi7BRQmI8FF8Cl3uBNryvbUyqcd1Lda29DeuoCONimHco69Bsh5o2xNja6vcMRuq7CrWrQn1X0fEXf7390j_Z0088TYc7</recordid><startdate>20201101</startdate><enddate>20201101</enddate><creator>Chen, Li-Hsiou</creator><creator>Chiu, Kuo-Liang</creator><creator>Hsia, Te-Chun</creator><creator>Lee, Yen-Hsien</creator><creator>Shen, Te-Chun</creator><creator>Li, Chia-Hsiang</creator><creator>Shen, Yi-Cheng</creator><creator>Chang, Wen-Shin</creator><creator>Tsai, Chia-Wen</creator><creator>Bau, DA-Tian</creator><general>International Institute of Anticancer Research</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20201101</creationdate><title>Significant Association of MMP2 Promoter Genotypes to Asthma Susceptibility in Taiwan</title><author>Chen, Li-Hsiou ; Chiu, Kuo-Liang ; Hsia, Te-Chun ; Lee, Yen-Hsien ; Shen, Te-Chun ; Li, Chia-Hsiang ; Shen, Yi-Cheng ; Chang, Wen-Shin ; Tsai, Chia-Wen ; Bau, DA-Tian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-f0257360c23d5a1d2818805edaeee859edb44e58cb01132a470223bcfc3057193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Asthma - epidemiology</topic><topic>Asthma - genetics</topic><topic>Case-Control Studies</topic><topic>Gene Frequency</topic><topic>Genetic Predisposition to Disease</topic><topic>Genotype</topic><topic>Humans</topic><topic>Matrix Metalloproteinase 2 - genetics</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Promoter Regions, Genetic</topic><topic>Taiwan - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Li-Hsiou</creatorcontrib><creatorcontrib>Chiu, Kuo-Liang</creatorcontrib><creatorcontrib>Hsia, Te-Chun</creatorcontrib><creatorcontrib>Lee, Yen-Hsien</creatorcontrib><creatorcontrib>Shen, Te-Chun</creatorcontrib><creatorcontrib>Li, Chia-Hsiang</creatorcontrib><creatorcontrib>Shen, Yi-Cheng</creatorcontrib><creatorcontrib>Chang, Wen-Shin</creatorcontrib><creatorcontrib>Tsai, Chia-Wen</creatorcontrib><creatorcontrib>Bau, DA-Tian</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>In vivo (Athens)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Li-Hsiou</au><au>Chiu, Kuo-Liang</au><au>Hsia, Te-Chun</au><au>Lee, Yen-Hsien</au><au>Shen, Te-Chun</au><au>Li, Chia-Hsiang</au><au>Shen, Yi-Cheng</au><au>Chang, Wen-Shin</au><au>Tsai, Chia-Wen</au><au>Bau, DA-Tian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Significant Association of MMP2 Promoter Genotypes to Asthma Susceptibility in Taiwan</atitle><jtitle>In vivo (Athens)</jtitle><addtitle>In Vivo</addtitle><date>2020-11-01</date><risdate>2020</risdate><volume>34</volume><issue>6</issue><spage>3181</spage><epage>3186</epage><pages>3181-3186</pages><issn>0258-851X</issn><eissn>1791-7549</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>Matrix metalloproteinase 2 (MMP2) is reported to be overexpressed in asthma; however, its genotypic contribution to asthma is not well studied. Therefore, we examined the association of MMP2 genotypes with asthma risk among Taiwanese. One hundred and ninety-eight asthma patients and 453 non-asthmatic subjects were determined with respect to their MMP2 -1306 (rs243845) and -735 (rs2285053) genotypes. CT and TT at MMP2 rs243845 are 17.7% and 1.5% among asthma cases, whereas their presence in healthy subjects is at 28.1% and 2.4%, respectively (p for trend=0.0118). In detail, the CT genotype in MMP2 rs243845 was associated with a decreased asthma risk [adjusted odds ratio (OR)=0.57, 95% confidence interval (CI)=0.37-0.78, p=0.0040], and the T allele conferred a significantly lower asthma risk compared to the wild-type C allele (adjusted OR=0.55, 95%CI=0.43-0.77, p=0.0042). No significance was found for MMP2 rs2285053. The genotype of CT in MMP2 rs243845 may serve as a novel biomarker in determining susceptibility to asthma in Taiwan.</abstract><cop>Greece</cop><pub>International Institute of Anticancer Research</pub><pmid>33144422</pmid><doi>10.21873/invivo.12153</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0258-851X
ispartof In vivo (Athens), 2020-11, Vol.34 (6), p.3181-3186
issn 0258-851X
1791-7549
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7811679
source PubMed Central
subjects Asthma - epidemiology
Asthma - genetics
Case-Control Studies
Gene Frequency
Genetic Predisposition to Disease
Genotype
Humans
Matrix Metalloproteinase 2 - genetics
Polymorphism, Single Nucleotide
Promoter Regions, Genetic
Taiwan - epidemiology
title Significant Association of MMP2 Promoter Genotypes to Asthma Susceptibility in Taiwan
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-23T06%3A27%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Significant%20Association%20of%20MMP2%20Promoter%20Genotypes%20to%20Asthma%20Susceptibility%20in%20Taiwan&rft.jtitle=In%20vivo%20(Athens)&rft.au=Chen,%20Li-Hsiou&rft.date=2020-11-01&rft.volume=34&rft.issue=6&rft.spage=3181&rft.epage=3186&rft.pages=3181-3186&rft.issn=0258-851X&rft.eissn=1791-7549&rft_id=info:doi/10.21873/invivo.12153&rft_dat=%3Cproquest_pubme%3E2457691674%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c387t-f0257360c23d5a1d2818805edaeee859edb44e58cb01132a470223bcfc3057193%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2457691674&rft_id=info:pmid/33144422&rfr_iscdi=true